Depletion of O6-methylguanine-DNA methyltransferase activity and potentiation of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3 (2-chloroethyl)-3-nitro-sourea antitumor effect by streptozotocin
- 1 March 1993
- journal article
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 5 (1), 48-52
- https://doi.org/10.1007/bf02997493
Abstract
O6-methylguanine-DNA Methyltransferase (MGMT) can specifically repair the DNA demage induced by chloroethylnitrosoureas (CENU) such as 1-(4-amino-2-mcthja-pyrimidinyl) methyl- 3- (2- chloroethyl)- 3-nitrosourea (ACNU), constituting the molecular basis of tumor cell resistance to CENU. The present study demonstrated that sensitization of resistant tumor cells to ACNU could be achieved by streptozotocin (STZ) treatment which could deplete MGMT activityin vitro andin vivo. It suggested that depletion of the molecular basis of tumor cell resistance to chemotherapeutic agents might be a practicable way to improve the effectiveness of tumor chemotherapy.Keywords
This publication has 4 references indexed in Scilit:
- Absence of mutations in the functional parts of the p120-GAP gene in carcinogen-induced mouse liver tumorsCarcinogenesis: Integrative Cancer Research, 1992
- Phase I Study of Streptozocin- and Carmustine-Sequenced Administration in Patients With Advanced CancerJNCI Journal of the National Cancer Institute, 1992
- O6-Methylguanine-DNA methyltransferase activity in human liver tumorsCarcinogenesis: Integrative Cancer Research, 1991
- Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoureaCarcinogenesis: Integrative Cancer Research, 1989